Syneos Health Signs New Service Agreement With Pfizer
This agreement builds on a longstanding relationship where
“Our ability to deliver deep therapeutic expertise, while bringing forward insights that can facilitate shorter and more efficient trials, has proven to be advantageous in our work with Pfizer,” said
|Syneos Health Investor Relations Contact:|
|Senior Vice President, Investor Relations||Executive Director,
|+1 919 745 2745||+1 202 210 5992|
Source: Syneos Health, Inc.